AGT and Hepatic fibrosis: Using an in vitro model of hepatic fibrosis in LX-2 cells, researchers reported that treatment with Ang II increased hematopoietic stem cell (HSC) activity, inflammation, ER stress, ROS production, and expression of ECM-related proteins (α-SMA, Col I, and Col III) (65).